Oaktop Capital Management II’s Neurotrope, Inc. Common NTRP Stock Holding History

Oaktop Capital Management II’s Portfolio NTRP Stock Details NTRP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-116,845	Closed	-$95K	–	19
2019 Q3	$95K	Hold	116,845	–	–	0.02%	17
2019 Q2	$937K	Hold	116,845	–	–	0.2%	16
2019 Q1	$637K	Hold	116,845	–	–	0.13%	16
2018 Q4	$417K	Hold	116,845	–	–	0.12%	17
2018 Q3	$1.03M	Hold	116,845	–	–	0.23%	16
2018 Q2	$1.13M	Hold	116,845	–	–	0.25%	16
2018 Q1	$951K	Hold	116,845	–	–	0.2%	16
2017 Q4	$823K	Hold	116,845	–	–	0.17%	18
2017 Q3	$603K	Hold	116,845	–	–	0.1%	20
2017 Q2	$1.09M	Buy	116,845 +71,867	+160%	+$768K	0.2%	19
2017 Q1	$860K	Buy	+44,978	New	+$852K	0.17%	19

Other funds holding NTRP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

NRS

Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Oaktop Capital Management II's NTRP Position: Q4 2019 in Review

Oaktop Capital Management II sold out of Neurotrope, Inc. Common (NTRP) in Q4 2019, closing a stake of 116,845 shares — an estimated $95K sold.

Oaktop Capital Management II first reported a position in NTRP in Q1 2017 and held it in 11 quarters. The position peaked at $1.13M in Q2 2018. 21 funds tracked by Wall St. Rank hold NTRP as of Q4 2019.

Oaktop Capital Management II reported no remaining Neurotrope, Inc. Common position as of Q4 2019 after selling out during the quarter.
Oaktop Capital Management II sold 116,845 Neurotrope, Inc. Common shares in Q4 2019, an estimated $95K.
Oaktop Capital Management II first reported a position in Neurotrope, Inc. Common in Q1 2017 and held it in 11 quarters.
Oaktop Capital Management II's Neurotrope, Inc. Common position peaked at $1.13M in Q2 2018.
21 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q4 2019.

Based on Oaktop Capital Management II's 13F filing for Q4 2019, filed 3 Feb 2020.